Previous 10 | Next 10 |
2023-08-10 22:38:02 ET scPharmaceuticals Inc. (SCPH) Q2 2023 Earnings Conference Call August 10, 2023 16:30 ET Company Participants PJ Kelleher - Investor Relations John Tucker - Chief Executive Officer Steve Parsons - Senior Vice President, Commercial Rachae...
2023-08-10 16:10:49 ET scPharmaceuticals press release ( NASDAQ: SCPH ): Q2 GAAP EPS of -$0.36 beats by $0.01 . Revenue of $1.63M beats by $0.01M . For further details see: scPharmaceuticals GAAP EPS of -$0.36 beats by $0.01, revenue of $1.63M beats by $0...
Generated net FUROSCIX® revenue of $1.6 million Ended Q2 2023 with cash, cash equivalents and short-term investments o f $102.9 million Company to host investor conference call and webcast today, Thursday, August 10, at 4:30pm ET BURLINGTON, Mass., Aug. 10, 2023 (...
BURLINGTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that scPharmace...
BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today a...
2023-07-24 17:30:42 ET Gainers: Medallion Financial ( MFIN ) +8% . NextGen Healthcare ( NXGN ) +7% . F5 ( FFIV ) +7% . Presto Automation ( PRST ) +5% . scPharmaceuticals ( SCPH ) +4% . Losers: SoundHound ...
2023-06-29 23:05:38 ET Summary scPharmaceuticals' Furoscix dose-filling rates increased by 55% month over month in May. Despite the lower figures than market expectations, SCPH stock price has fallen, but we expect an inflection point in 2H 2023 as more coverage is added. Risk...
2023-06-23 08:22:14 ET Pharmaceutical company scPharmaceuticals ( NASDAQ: SCPH ) said on Friday that it expects to be added to the small-cap Russell 2000 and broad-market Russell 3000 indexes. The addition is effective on June 26 market open. SCPH shares were tra...
BURLINGTON, Mass., June 23, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today a...
2023-06-07 17:31:50 ET Gainers: 4D Molecular Therapeutics( FDMT ) +21% . Semtech Corporation ( SMTC ) +15% . Acorda Therapeutics ( ACOR ) +10% . scPharmaceuticals ( SCPH ) +7% . Kezar Life Sciences ( KZR ) +6% . Loser...
News, Short Squeeze, Breakout and More Instantly...
scPharmaceuticals Inc. Company Name:
SCPH Stock Symbol:
NASDAQ Market:
scPharmaceuticals Inc. Website:
BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today an...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 208.7% to $0.1698 on volume of 325,435,783 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 76.7% to $0.5039 on volume of 314,353,673 shares Greenwave Technology Solutions Inc. (GWAV) ros...
Generated 1Q 2024 net FUROSCIX ® revenue of $6.1 million, despite an estimated 10% impact to doses filled resulting from the Change Healthcare cyberattack Ended 1Q 2024 with cash and cash equivalents o f $58.4 million Company to host investor conference call and web...